GRI Bio, Inc. (GRI) (CIK 0001824293) (GRI)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 30, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 30, 2026 | UPLOAD | Concern from SEC | Moderate | The SEC has notified GRI Bio, Inc. that it will not review their registration statement filed on January 30, 2026. The correspondence emphasizes the company's responsibility for t… | Read Filing EDGAR |
| Jan. 30, 2026 | CORRESP | Neutral/Informational | Moderate | GRI Bio, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, filed on January 30, 2026. The company is seeking to… | Read Filing EDGAR |
| Dec. 9, 2025 | CORRESP | Neutral/Informational | Moderate | GRI Bio, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have the registration … | Read Filing EDGAR |
| Dec. 9, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from GRI Bio, Inc. pertains to their request for the acceleration of the effective date of their registration statement on Form S-1. H.C. Wainwright & Co., acti… | Read Filing EDGAR |